Search for: "Roche Pharmaceuticals Inc."
Results 141 - 160
of 222
Sorted by Relevance
|
Sort by Date
1 Feb 2016, 10:43 am
Hoffman-La Roche Ltd., 580 F.3d 1340,1369 (Fed. [read post]
9 Jan 2014, 1:37 pm
Hoffman-La Roche, Inc., 2010 WL 3034453, at *22 (N.J. [read post]
2 Feb 2018, 1:31 pm
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Case 2016-1284, 2016-1787 (Fed. [read post]
6 May 2016, 12:30 pm
Hoffman-La Roche, Inc., 2007 WL 4042757, at *3 (N.D. [read post]
17 Sep 2009, 4:30 am
Medtronic, Inc., 128 S. [read post]
27 Dec 2007, 7:09 am
Hoffman-La Roche, Inc., 917 A.2d 767 (N.J. 2007). [read post]
3 Jun 2010, 1:37 pm
Hoffmann-La Roche Inc., 892 A.2d 694, 705 (N.J. [read post]
22 Jun 2011, 2:00 am
Roche Molecular Systems, Inc., holding that the Bayh-Dole Act does not automatically vest title of federally funded inventions to federal contractors (e.g., universities). [read post]
22 Jun 2011, 2:00 am
Roche Molecular Systems, Inc., holding that the Bayh-Dole Act does not automatically vest title of federally funded inventions to federal contractors (e.g., universities). [read post]
6 Nov 2014, 5:00 am
Roche Laboratories, Division of Hoffman-LaRoche, Inc., 684 P.2d 1187, 1189 (N.M. [read post]
18 Feb 2010, 10:34 am
Mylan followed Sandoz Pharmaceuticals Corp. v. [read post]
27 Aug 2012, 9:31 am
Hoffmann-La Roche Ltd., 580 F.3d 1340 (Fed. [read post]
27 Aug 2012, 9:31 am
Hoffmann-La Roche Ltd., 580 F.3d 1340 (Fed. [read post]
26 Jul 2010, 10:41 pm
Roche Laboratories is already producing and marketing a new test called the “AmpliChip CYP450”. [read post]
23 Mar 2007, 11:35 am
., Beckman Coulter, Bridgestone Americas, Bristol-Myers Squibb, Cargill Incorporated, Caterpillar, Cephalon, CheckFree, Corning, Dow Chemical, Eastman Chemical, Electronics for Imaging, E.I. du Pont (DuPont), Eli Lilly, ExxonMobil, General Electric, Genzyme, GlaxoSmithKline, Henkel Corporation, Hoffman-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals, Monsanto, Motorola, Novartis, Patent Café.com Inc., Pfizer, Procter… [read post]
1 Jul 2009, 7:14 am
OHIM decision in Laboratorios Andrómaco, S.A. v OTC Pharma International B V (Class 46) India: Valgancyclovir hearings and the need for more transparency: Roche v Cipla (Spicy IP) Japan approves first follow-on biologic (Patent Docs) UK: Journal of Intellectual Property Law & Practice note on ‘Paediatric extensions: the requirement of a compliance statement’ on UK IPO decision in Merck and Co, Inc (The SPC Blog) US: Sen Nelson introduces s… [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
22 Sep 2022, 9:54 am
AbbVie Inc, 7th U.S. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
